What does Revive Therapeutics Ltd. do?

Revive Therapeutics Ltd. (RVV.CN) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is RVV.CN's market cap?

Revive Therapeutics Ltd. (RVV.CN) has a market capitalization of approximately $10.9 million, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does RVV.CN pay a dividend?

No — Revive Therapeutics Ltd. (RVV.CN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is RVV.CN profitable?

Revive Therapeutics Ltd. (RVV.CN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

RVV.CN

Revive Therapeutics Ltd.

CNQ·Drug Manufacturers, Specialty & Generic · Healthcare

C$0.03C$0.01−16.67%

Market capC$10.89M·Market closed·Aug 27 4:39 PM UTC

Price Chart

C$0.03−C$0.01 (−16.67%)today

−94.12%CAGR −43.26%

Select date range

FromTo

Jul 12, 2013Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

RVV.CN does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 27

Last Report DateMay 27

Reported vs Estimate−C$0.00

Earnings Surprise—

FinancialsFinancials Tab

RevenueC$0.00

Net Income−C$10.62M

Net Margin—

Operating Cash Flow−C$156.71K

Capital ExpendituresC$4.00

Free Cash Flow−C$156.71K

Return on Equity—

Return on Invested Capital11.9%

Net DebtC$48.11K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for RVV.CN and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how RVV.CN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RVV.CN and 80,000+ other tickers.

About Revive Therapeutics Ltd.

Revive Therapeutics Ltd., a life sciences firm, specializes in the research and development of treatments for rare disorders and infectious diseases. The company’s pharmaceutical pipeline features a cannabinoid portfolio focused on rare inflammatory ailments. Currently, it is advancing Bucillamine through a Phase 3 clinical study for infectious diseases like influenza and COVID-19. Its psychedelic programs include Psilocybin, undergoing a Phase 1 clinical study for methamphetamine use disorder, and Psilocin, which is being investigated for applications in depression, anxiety, bipolar…

CEO: Michael Frank
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: CNQ
Employees: 2
Website: www.revivethera.com

Peers

Latest News

News Tab

No recent news available.

Frequently Asked Questions About RVV.CN

What does Revive Therapeutics Ltd. do?: Revive Therapeutics Ltd. (RVV.CN) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is RVV.CN's market cap?: Revive Therapeutics Ltd. (RVV.CN) has a market capitalization of approximately $10.9 million, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does RVV.CN pay a dividend?: No — Revive Therapeutics Ltd. (RVV.CN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is RVV.CN profitable?: Revive Therapeutics Ltd. (RVV.CN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.